Fri, September 27, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 22, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 6, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
Mon, June 5, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 24, 2023
[ 12:00 AM ] - WOPRAI
Fri, January 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 12, 2022
[ 12:00 AM ] - WOPRAI
Wed, November 23, 2022
[ 12:00 AM ] - WOPRAI
Tue, November 22, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
Fri, November 11, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 10, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 2, 2022
[ 12:00 AM ] - WOPRAI
Fri, October 21, 2022
[ 12:00 AM ] - WOPRAI
Thu, October 13, 2022
[ 12:00 AM ] - WOPRAI
Thu, August 18, 2022
[ 12:00 AM ] - WOPRAI
Wed, August 10, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 3, 2022
[ 12:00 AM ] - WOPRAI
Wed, July 27, 2022
[ 12:00 AM ] - WOPRAI
Fri, July 1, 2022
[ 12:00 AM ] - WOPRAI
Mon, June 13, 2022
[ 12:00 AM ] - WOPRAI
Fri, May 27, 2022
Andrew Berens Downgraded (AGIO) to Hold and Decreased Target to $56 on, Sep 27th, 2024
Andrew Berens of Leerink Partners, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Decreased Target from $60 to $56 on, Sep 27th, 2024.
Andrew has made no other calls on AGIO in the last 4 months.
There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tessa Romero of "JP Morgan" Initiated at Hold and Held Target at $46 on, Thursday, June 13th, 2024
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024
These are the ratings of the 2 analyists that currently disagree with Andrew
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Friday, September 20th, 2024
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Thursday, September 19th, 2024
Contributing Sources